Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
VistaGen Therapeutics, Inc. (VTGN) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
$1.06M |
|
$-29.36M |
|
-- |
|
$1.06M |
|
$34.09M |
|
$-33.02M |
|
$3.66M |
|
$-29.36M |
|
$-29.36M |
|
$-29.35M |
|
$-29.35M |
|
$-29.36M |
|
$-29.35M |
|
$-33.02M |
|
$-32.89M |
|
19.35M |
|
19.35M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$120.67M |
|
$0.43M |
|
$2.98M |
|
$123.65M |
|
$5.12M |
|
-- |
|
$4.24M |
|
$9.37M |
|
$114.29M |
|
$114.29M |
|
$114.29M |
|
27.03M |
|
| Cash Flow Statement Financials | |
$-25.81M |
|
$-0.06M |
|
$128.40M |
|
$16.64M |
|
$119.17M |
|
$102.53M |
|
$2.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.55 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-3103.48% |
|
-3103.48% |
|
-3091.54% |
|
-2759.21% |
|
-2759.59% |
|
$-25.87M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-25.68% |
|
-25.68% |
|
-23.74% |
|
-25.68% |
|
$4.23 |
|
$-1.34 |
|
$-1.33 |
|